Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
warent
on Nov 28, 2018
|
parent
|
context
|
favorite
| on:
FDA promised a ‘lower-cost option’ to EpiPen, but ...
Unless I'm misunderstanding, it has nothing to do with production cost in the US, and everything to do with the arbitrarily high market value of the drug.
russdill
on Nov 28, 2018
[–]
It's not the drug, it's the FDA approved one use delivery system. Epinephrine is dirt cheap.
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
